Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AXGN NYSE:BFLY NASDAQ:PTHL NASDAQ:SMLR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAXGNAxoGen$11.28-3.0%$10.92$7.34▼$21.00$529.68M1.04517,535 shs676,057 shsBFLYButterfly Network$1.87+1.1%$2.17$0.90▼$4.98$457.48M2.463.25 million shs2.48 million shsPTHLPheton$22.22+2.3%$13.80$1.32▼$28.77$143.03MN/A357,781 shs1.89 million shsSMLRSemler Scientific$41.24-5.4%$38.38$21.77▼$81.56$596.81M1.39579,377 shs622,725 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAXGNAxoGen-3.01%-5.13%+21.42%-27.55%+18.99%BFLYButterfly Network+0.27%+3.31%-13.63%-19.91%+55.83%PTHLPheton+2.25%+5.76%+22.76%+693.57%+2,221,999,900.00%SMLRSemler Scientific-5.41%-9.42%+29.12%+26.93%+13.89%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAXGNAxoGen2.1696 of 5 stars3.51.00.00.01.82.50.6BFLYButterfly Network2.4203 of 5 stars3.51.00.00.02.52.50.6PTHLPhetonN/AN/AN/AN/AN/AN/AN/AN/ASMLRSemler Scientific2.6347 of 5 stars3.72.00.00.03.02.50.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAXGNAxoGen 3.00Buy$24.50117.20% UpsideBFLYButterfly Network 3.00Buy$3.5087.17% UpsidePTHLPheton 0.00N/AN/AN/ASMLRSemler Scientific 3.33Buy$89.00115.81% UpsideCurrent Analyst Ratings BreakdownLatest PTHL, AXGN, BFLY, and SMLR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/9/2025SMLRSemler ScientificMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy$95.007/8/2025SMLRSemler ScientificBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$101.007/1/2025BFLYButterfly NetworkCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$3.005/13/2025AXGNAxoGenCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$26.00 ➝ $24.005/5/2025BFLYButterfly NetworkLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$5.00 ➝ $4.00(Data available from 7/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAXGNAxoGen$187.34M2.74N/AN/A$2.36 per share4.78BFLYButterfly Network$82.06M5.64N/AN/A$0.79 per share2.37PTHLPheton$450K324.91N/AN/A$0.94 per share23.64SMLRSemler Scientific$56.29M10.03$4.23 per share9.74$24.90 per share1.66Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAXGNAxoGen-$9.96M-$0.15N/AN/AN/A-3.68%-7.09%-3.67%8/6/2025 (Estimated)BFLYButterfly Network-$72.49M-$0.29N/AN/AN/A-75.56%-29.97%-21.13%8/7/2025 (Estimated)PTHLPheton-$660KN/A0.00∞N/AN/AN/AN/AN/ASMLRSemler Scientific$40.90M-$2.61N/A∞N/A-60.69%19.75%15.47%8/4/2025 (Estimated)Latest PTHL, AXGN, BFLY, and SMLR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025AXGNAxoGen$0.06N/AN/AN/A$52.61 millionN/A8/7/2025Q2 2025BFLYButterfly Network-$0.07N/AN/AN/A$23.91 millionN/A5/13/2025Q1 2025SMLRSemler ScientificN/A-$0.76N/A-$6.74N/A$8.84 million5/2/2025Q1 2025BFLYButterfly Network-$0.09-$0.06+$0.03-$0.06$21.16 million$21.23 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAXGNAxoGenN/AN/AN/AN/AN/ABFLYButterfly NetworkN/AN/AN/AN/AN/APTHLPhetonN/AN/AN/AN/AN/ASMLRSemler ScientificN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAXGNAxoGen0.634.282.65BFLYButterfly NetworkN/A6.064.43PTHLPhetonN/A12.3912.17SMLRSemler Scientific0.590.520.51Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAXGNAxoGen80.29%BFLYButterfly Network37.85%PTHLPhetonN/ASMLRSemler Scientific49.37%Insider OwnershipCompanyInsider OwnershipAXGNAxoGen2.78%BFLYButterfly Network25.18%PTHLPhetonN/ASMLRSemler Scientific30.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAXGNAxoGen45045.54 million44.28 millionOptionableBFLYButterfly Network460247.29 million185.02 millionOptionablePTHLPheton116.58 millionN/AN/ASMLRSemler Scientific12013.69 million9.55 millionNot OptionablePTHL, AXGN, BFLY, and SMLR HeadlinesRecent News About These CompaniesRosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLRJuly 18 at 5:36 PM | prnewswire.comSemler Scientific Advances to 14th-Largest Public Bitcoin Holder Following $25 Million InvestmentJuly 18 at 2:36 AM | coinspeaker.comSemler Scientific Becomes 14th-Largest Public Bitcoin Holder After $25M BTC BuyJuly 18 at 2:36 AM | finance.yahoo.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJuly 17 at 6:59 PM | globenewswire.com9,970 Shares in Semler Scientific Inc. (NASDAQ:SMLR) Purchased by Alps Advisors Inc.July 16 at 4:06 AM | marketbeat.comSemler Scientific (NASDAQ:SMLR) Trading Down 8.2% - Here's What HappenedJuly 15, 2025 | marketbeat.com135 Public Companies That Hold Bitcoin — And Why It MattersJuly 15, 2025 | schaeffersresearch.comSemler Scientific Inc (SMLR) - Investing.comJuly 12, 2025 | investing.comSemler Scientific (NASDAQ:SMLR) Rating Increased to Strong-Buy at Maxim GroupJuly 12, 2025 | americanbankingnews.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJuly 11, 2025 | globenewswire.comSemler Scientific (NASDAQ:SMLR) Research Coverage Started at BenchmarkJuly 11, 2025 | americanbankingnews.comSemler Scientific (NASDAQ:SMLR) Stock Price Up 8% - Here's What HappenedJuly 10, 2025 | marketbeat.comMaxim Group Initiates Coverage of Semler Scientific (SMLR) with Buy RecommendationJuly 10, 2025 | msn.comSemler Scientific Stock Gets Relative Strength Rating UpgradeJuly 9, 2025 | msn.comSemler Scientific (NASDAQ:SMLR) Now Covered by Maxim GroupJuly 9, 2025 | marketbeat.comBenchmark Initiates Coverage of Semler Scientific (SMLR) with Buy RecommendationJuly 9, 2025 | msn.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJuly 8, 2025 | globenewswire.comSemler Scientific (NASDAQ:SMLR) Coverage Initiated by Analysts at BenchmarkJuly 8, 2025 | marketbeat.comRosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLR - MorningstarJuly 7, 2025 | morningstar.comMNews Explorer — Metaplanet Makes Biggest Bitcoin Buy Yet as Semler Boosts BTC TreasuryJuly 7, 2025 | decrypt.coDThe Blockchain Group, Smarter Web Company and Semler Scientific buy over 500 Bitcoin on MondayJuly 7, 2025 | coinjournal.netNew MarketBeat Followers Over TimeMedia Sentiment Over TimePTHL, AXGN, BFLY, and SMLR Company DescriptionsAxoGen NASDAQ:AXGN$11.28 -0.35 (-3.01%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$11.30 +0.02 (+0.13%) As of 07/18/2025 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.Butterfly Network NYSE:BFLY$1.87 +0.02 (+1.08%) Closing price 07/18/2025 03:59 PM EasternExtended Trading$1.88 +0.01 (+0.48%) As of 07/18/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.Pheton NASDAQ:PTHL$22.22 +0.49 (+2.25%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$22.68 +0.46 (+2.05%) As of 07/18/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.Semler Scientific NASDAQ:SMLR$41.24 -2.36 (-5.41%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$41.32 +0.08 (+0.19%) As of 07/18/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
